Chairmen's summary

Affiliations

Lennart Andersson et al. Scand J Urol Nephrol Suppl. 2008 Sep.

. 2008 Sep:(218):7-11.

doi: 10.1080/03008880802399684.

¹ WHO Collaborating Center for Urological Tumors, Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Similar articles

Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.
Grossman HB, Stenzl A, Moyad MA, Droller MJ. Grossman HB, et al. Scand J Urol Nephrol Suppl. 2008 Sep;(218):213-33. doi: 10.1080/03008880802284258. Scand J Urol Nephrol Suppl. 2008. PMID: 18815935 Review.
Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
Kakizoe T, Mucci LA, Albertsen PC, Droller MJ. Kakizoe T, et al. Scand J Urol Nephrol Suppl. 2008 Sep;(218):191-212. doi: 10.1080/03008880802284936. Scand J Urol Nephrol Suppl. 2008. PMID: 18815934 Review.
Occupational risk factors.
Delclos GL, Lerner SP. Delclos GL, et al. Scand J Urol Nephrol Suppl. 2008 Sep;(218):58-63. doi: 10.1080/03008880802284423. Scand J Urol Nephrol Suppl. 2008. PMID: 18815918 Review.
Tobacco smoking and risk of bladder cancer.
Boffetta P. Boffetta P. Scand J Urol Nephrol Suppl. 2008 Sep;(218):45-54. doi: 10.1080/03008880802283664. Scand J Urol Nephrol Suppl. 2008. PMID: 18815916 Review.
Bladder cancer: from pathogenesis to prevention.
Andersson L, Droller MJ. Andersson L, et al. Scand J Urol Nephrol Suppl. 2008 Sep;(218):5-6. doi: 10.1080/03008880802283789. Scand J Urol Nephrol Suppl. 2008. PMID: 18815911 No abstract available.